Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,427 | 381 | 88.3% |
| Honoraria | $1,200 | 1 | 11.2% |
| Education | $47.34 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,013 | 64 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,574 | 114 | $0 (2023) |
| La Jolla Pharmaceutical Company | $1,475 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,164 | 54 | $0 (2023) |
| Grifols USA, LLC | $386.23 | 13 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $351.17 | 27 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $289.98 | 12 | $0 (2023) |
| Mylan Specialty L.P. | $277.36 | 8 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $276.23 | 6 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $272.82 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,416 | 39 | GlaxoSmithKline, LLC. ($336.65) |
| 2022 | $1,883 | 65 | AstraZeneca Pharmaceuticals LP ($455.98) |
| 2021 | $963.50 | 57 | AstraZeneca Pharmaceuticals LP ($346.74) |
| 2020 | $699.76 | 24 | AstraZeneca Pharmaceuticals LP ($171.41) |
| 2019 | $1,845 | 85 | Boehringer Ingelheim Pharmaceuticals, Inc. ($325.74) |
| 2018 | $2,971 | 72 | La Jolla Pharmaceutical Company ($1,327) |
| 2017 | $895.62 | 44 | GlaxoSmithKline, LLC. ($250.22) |
All Payment Transactions
386 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $14.65 | General |
| 09/28/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: PULMONOLOGY | ||||||
| 09/27/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Inflammation | ||||||
| 09/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: PULMONOLOGY | ||||||
| 08/08/2023 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $158.41 | General |
| Category: Immunology and Neurology | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/20/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 06/01/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $29.75 | General |
| Category: SLEEP MEDICINE | ||||||
| 05/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $116.20 | General |
| Category: PULMONOLOGY | ||||||
| 05/15/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,830 | 2,910 | $616,090 | $313,650 |
| 2022 | 15 | 1,741 | 2,981 | $654,594 | $326,659 |
| 2021 | 20 | 2,128 | 3,335 | $732,906 | $367,874 |
| 2020 | 21 | 2,114 | 3,376 | $672,862 | $349,398 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 210 | 489 | $177,507 | $84,472 | 47.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 320 | 781 | $105,435 | $74,794 | 70.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 458 | 688 | $134,160 | $64,960 | 48.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 238 | 248 | $65,968 | $33,934 | 51.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 151 | 239 | $28,875 | $15,118 | 52.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 21 | 23 | $20,148 | $11,158 | 55.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 21 | 22 | $18,348 | $10,368 | 56.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $8,925 | $4,490 | 50.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 76 | 77 | $10,395 | $3,109 | 29.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 76 | 77 | $7,700 | $2,955 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 35 | $4,900 | $2,297 | 46.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 76 | 77 | $10,395 | $2,176 | 20.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 84 | 86 | $19,350 | $2,140 | 11.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 15 | 18 | $2,934 | $1,579 | 53.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 15 | 15 | $1,050 | $98.25 | 9.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 211 | 637 | $231,231 | $113,186 | 48.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 337 | 823 | $111,105 | $67,423 | 60.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 327 | 520 | $101,400 | $46,864 | 46.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 268 | 285 | $75,810 | $44,462 | 58.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 163 | 260 | $31,200 | $14,874 | 47.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 27 | 30 | $26,280 | $14,351 | 54.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 16 | 16 | $13,344 | $7,541 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 88 | $12,320 | $4,685 | 38.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 69 | 70 | $9,450 | $2,839 | 30.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 69 | 70 | $6,968 | $2,778 | 39.9% |
About Dr. Paul Smith, MD
Dr. Paul Smith, MD is a Critical Care Medicine healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568464006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Smith, MD has received a total of $10,674 in payments from pharmaceutical and medical device companies, with $1,416 received in 2023. These payments were reported across 386 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($9,427).
As a Medicare-enrolled provider, Smith has provided services to 7,813 Medicare beneficiaries, totaling 12,602 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Orange City, FL
- Active Since 08/15/2005
- Last Updated 06/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1568464006
Products in Payments
- GIAPREZA (Drug) $1,475
- NUCALA (Biological) $747.35
- OFEV (Drug) $544.40
- DUPIXENT (Biological) $483.47
- TRELEGY ELLIPTA (Drug) $470.07
- BREZTRI (Drug) $363.59
- STIOLTO RESPIMAT (Drug) $306.04
- BEVESPI AEROSPHERE (Drug) $301.80
- ACTHAR (Biological) $289.11
- FASENRA (Biological) $257.65
- TAGRISSO (Drug) $247.23
- GLASSIA (Biological) $243.68
- FASENRA (Drug) $232.76
- SYMBICORT (Drug) $212.60
- Yupelri (Drug) $197.11
- Prolastin-C Liquid (Biological) $180.24
- Esbriet (Biological) $175.05
- TEZSPIRE (Biological) $174.70
- XYWAV (Drug) $169.90
- CHARTIS CATHETER (Device) $168.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Orange City
Radhika Verma, Md, MD
Critical Care Medicine — Payments: $18,454
Kurt Bowman, Md, MD
Critical Care Medicine — Payments: $16,117
Mrs. Shahana Masood, M.d, M.D
Critical Care Medicine — Payments: $10,597
Kristal Carthan, Md, MD
Critical Care Medicine — Payments: $8,413
Arianne Bennett-Venner, Md, MD
Critical Care Medicine — Payments: $7,575
Edward Scanlon, Md, MD
Critical Care Medicine — Payments: $3,567